CG Oncology (CGON) Inventory (2025 - 2026)

CG Oncology (CGON) reported Inventory of $1.5 million for Q1 2026, down 4.6% quarter-over-quarter from $1.6 million in Q4 2025.

CG Oncology (CGON) Inventory (2025 - 2026) Analysis & Trends

CG Oncology has reported Inventory for 2 years, with the latest figure at $1.5 million in Q1 2026.

For the quarter ending Q1 2026, Inventory changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (changed N/A YoY), and the FY2025 full-year result was $1.6 million, changed N/A from the prior year.
Inventory for Q1 2026 stood at $1.5 million, down from $1.6 million in the prior quarter.
The five-year high for Inventory was $1.6 million in Q4 2025, with the low at $1.5 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	32.00 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	1.77 Bn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	CG Oncology	5.16 Bn	5.16 Bn	-1.88 Mn	1.49 Mn

Download Data